Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Quality Biosimilars Manufacturing

FDA To Update Quality Metrics Guidance

  • Analysis

Executive Summary

It's the only addition to the agency's 2016 agenda.

You may also be interested in...



False Claims, Enforcement Changes Possible Under Trump Administration

Pharma lawyers suggest that much depends on who is selected for key posts – except for the Supreme Court.

Biosimilar Interchangeability May Be Losing Luster As Approval Goal

Pricing now may mean more to payers than whether the product is interchangeable.

Biosimilar Interchangeability May Be Losing Luster As Approval Goal

Pricing now may mean more to payers than whether the product is interchangeable.

Table

View full table

Related Content

Pink Sheet
Pink Sheet
Pink Sheet
Pink Sheet
Pink Sheet
Pink Sheet
Pink Sheet

Topics

Related Companies

Tags:
Quality Biosimilars Manufacturing
Latest Headlines

EU Multistakeholder Project Aims To Give eConsent The ‘Place It Deserves’

EU Regulatory Reforms Mean Many Orphan Drug Producers Won’t Benefit From Incentives

Canada Proposes List Of ‘Critical Products’ & More Agile Regulation To Address Shortages

Third Time’s A Charm? US FDA Once Again Proposes Mandatory Consumer Rx Info

See All
UsernamePublicRestriction

Register

PS118931

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By